|1.||Yamaguchi, Masayoshi: 11 articles (01/2012 - 02/2004)|
|2.||Rohan, Thomas E: 8 articles (03/2012 - 01/2002)|
|3.||Sugiura, Minoru: 7 articles (09/2015 - 01/2006)|
|4.||Uchiyama, Satoshi: 7 articles (08/2008 - 02/2004)|
|5.||Willett, Walter C: 6 articles (05/2013 - 01/2004)|
|6.||Ogawa, Kazunori: 5 articles (03/2015 - 01/2006)|
|7.||van den Brandt, Piet A: 5 articles (03/2012 - 08/2002)|
|8.||Miller, Anthony B: 5 articles (03/2012 - 01/2002)|
|9.||Kolonel, Laurence N: 4 articles (08/2013 - 03/2005)|
|10.||Wilkens, Lynne R: 4 articles (08/2013 - 03/2005)|
|1.||Lung Neoplasms (Lung Cancer)
09/01/2003 - "The present study lends additional credence to prior experimental and epidemiological data in support of the hypothesis that dietary beta-cryptoxanthin is a chemopreventive agent for lung cancer in humans."
09/01/2003 - "Dietary cryptoxanthin and reduced risk of lung cancer: the Singapore Chinese Health Study."
08/01/2011 - "In epidemiologic studies, high intake of β-cryptoxanthin has been associated with a decreased risk of lung cancer, particularly among current smokers. "
01/01/2007 - "We previously reported serum beta-cryptoxanthin levels being inversely associated with smoking-related lung cancer incidence in a cohort of Chinese men. "
11/01/2006 - "These findings suggest a mechanism of anti-proliferative action of beta-cryptoxanthin and indicate that beta-cryptoxanthin may be a promising chemopreventive agent against lung cancer."
|2.||Breast Neoplasms (Breast Cancer)
01/01/2016 - "However, no significant association was found between serum β-cryptoxanthin and the risk for breast cancer. "
01/01/2014 - "Plasma β-cryptoxanthin concentration was inversely associated with breast cancer risk (OR = 0.83, 95% CI = 0.71-0.96, Ptrend = 0.02). "
03/01/2012 - "Although the pooled RRs for quintile 5 for β-cryptoxanthin were not significant, inverse trends were observed for ER- and ER+ breast cancer (P-trend ≤ 0.05). "
01/01/1998 - "A nonsignificant gradient of decreasing risk of breast cancer with increasing serum beta-cryptoxanthin was apparent for all women. "
09/01/2009 - "However, high levels of plasma lycopene other than trans, 5- and 7-cis or trans alpha-cryptoxanthin were inversely associated with the risk of developing breast cancer. "
07/15/2007 - "Taking into account that the pharmacodynamics difference between beta-cryptoxanthin and atRA, beta-cryptoxanthin appears to exert beneficial effects on atherogenesis through RAR activation in the manner different from atRA."
01/01/2015 - "From the cross-sectional analyses from the Mikkabi Study, we found inverse associations of serum β-cryptoxanthin with the risks for atherosclerosis, insulin resistance, liver dysfunction, metabolic syndrome, low bone mineral density, and oxidative stress. "
06/01/1997 - "In conditional logistic regression adjusting for age, blood storage time, total cholesterol, and log-triglyceride concentrations, serum beta-cryptoxanthin and lutein plus zeaxanthin levels were inversely related to the extent of atherosclerosis (odds ratio [OR] per 1-SD increase: 0.75, 95% confidence interval [CI]: 0.59-0.94; and OR per 1-SD increase: 0.76, 95% CI: 0.59-0.95, respectively). "
02/01/2004 - "These findings suggest that higher levels of plasma oxygenated carotenoids (lutein, zeaxanthin, beta-cryptoxanthin) and alpha-carotene may be protective against early atherosclerosis."
11/01/2000 - "The aim of this study was to assess the relationship between plasma levels of carotenoids (alpha- and beta- carotene, lutein, lycopene, zeaxanthin, beta-cryptoxanthin), vitamins A and E, and atherosclerosis in the carotid and femoral arteries. "
03/01/2004 - "The present study demonstrates that beta-cryptoxanthin has a direct stimulatory effect on bone formation and an inhibitory effect on bone resorption in tissue culture in vitro."
07/01/2013 - "β-cryptoxanthin regulates bone resorption related-cytokine production in human periodontal ligament cells."
01/01/2012 - "β-cryptoxanthin has stimulatory effects on osteoblastic bone formation and inhibitory effects on osteoclastic bone resorption in vitro, thereby increasing bone mass. "
11/01/2009 - "beta-cryptoxanthin was demonstrated to stimulate osteoblastic bone formation and simultaneously repress osteoclastic bone resorption in vitro. "
04/01/2004 - "The carotenoid beta-cryptoxanthin has been shown to have an inhibitory effect on bone-resorping factor-stimulated bone resorption in rat bone tissues in vitro. "
01/01/2013 - "We examined the effects of β-cryptoxanthin, a typical carotenoid, on inflammatory periodontitis. "
10/01/2009 - "The adjusted odds ratio for high-threshold periodontitis in the lowest fifth relative to the highest fifth of beta-cryptoxanthin was 4.02 (p=0.003). "
01/01/2013 - "The protective effects of β-cryptoxanthin on inflammatory bone resorption in a mouse experimental model of periodontitis."
10/01/2009 - "It is concluded that low serum levels of a number of carotenoids, in particular beta-cryptoxanthin and beta-carotene, were associated with an increased prevalence of periodontitis in this homogenous group of 60-70-year-old Western European men."
10/01/2009 - "beta-Carotene and beta-cryptoxanthin were the only antioxidants that were associated with an increased risk of high-threshold severe periodontitis. "
|6.||Ascorbic Acid (Vitamin C)
|10.||Folic Acid (Vitamin M)